Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.2060
+0.0160 (8.42%)
Apr 15, 2026, 4:29 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 8.15 million as of April 15, 2026. Its market cap has decreased by -12.32% in one year.
Market Cap
8.15M
Enterprise Value
11.87M
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 8.15M, a decrease of -94.04%. That is a compound annual growth rate of -26.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 8.15M | -11.63% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 18.29M |
| Fusion Antibodies | 17.50M |
| Genflow Biosciences | 11.52M |
| Cizzle Biotechnology Holdings | 9.32M |
| Futura Medical | 6.92M |
| IXICO | 6.83M |
| CRISM Therapeutics | 6.08M |
| Thalia Therapeutics | 5.62M |